Posted in | News | Nanoanalysis | Nanobusiness

Advance Nanotech Granted Two Additional Patents by the United States Patent Office

Advance Nanotech, Inc. (OTCBB: AVNA) announced today that its Owlstone Nanotech, Inc. subsidiary has been been granted two additional patents by the United States Patent office. This issuance brings the total issued patent portfolio to four. Additionally, the Company has ten patent applications submitted and awaiting response and four patent applications pending submittal under PCT protection with the United States Patent and Trademark Office.

The recently issued patents cover technology developed by Owlstone used in both its core sensor system and surrounding components. The patents describe several methods and embodiments of a microchip spectrometer and a highly integrated means of sample ionization that fits within the confines of a microchip -- sample ionization is a required functionality for Owlstone's spectrometry solutions. In addition to utility within Owlstone's products, the patented ionization technology could be of benefit to other ion based analytical technologies.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Owlstone Nanotech. (2019, March 19). Advance Nanotech Granted Two Additional Patents by the United States Patent Office. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=10787.

  • MLA

    Owlstone Nanotech. "Advance Nanotech Granted Two Additional Patents by the United States Patent Office". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=10787>.

  • Chicago

    Owlstone Nanotech. "Advance Nanotech Granted Two Additional Patents by the United States Patent Office". AZoNano. https://www.azonano.com/news.aspx?newsID=10787. (accessed November 21, 2024).

  • Harvard

    Owlstone Nanotech. 2019. Advance Nanotech Granted Two Additional Patents by the United States Patent Office. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=10787.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.